Pain News and Research

Latest Pain News and Research

Focus on motor neurone disease

Motor neurone disease (MND), also known as amyotrophic lateral sclerosis, is a degenerative disease of unknown cause which causes patients to lose basic motor functions and has a devastating effect on them and their families.

17 Jun 2007

Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced the presentation of additional data that showed that the safety profile of Enbrel, (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

17 Jun 2007

Early palliative care interventions can reduce length of stay in ICU

Researchers at the University of Rochester Medical Center have found that early palliative care interventions can reduce the length of stay for seriously ill patients in the medical intensive care unit (MICU) by more than seven days without having an impact on mortality rates.

17 Jun 2007

Preventing and treating common foot conditions

Add foot problems to the long list of conditions that being overweight can cause or exacerbate, says Foot Care Basics: Preventing and treating common foot conditions , a newly updated report from Harvard Medical School.

17 Jun 2007

New research in animals uncovers another mechanism of cholesterol lowering drug ezetimibe

It had previously been thought that the drug works by preventing cells in the intestine from absorbing cholesterol. The new research suggests that Zetia also works in the liver.

17 Jun 2007

Study on hand osteoarthritis

In just two years, patients with hand osteoarthritis (OA) experienced a significant increase in pain and functional limitations, according to new data presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. Statistically significant radiological progression was also detected in 20% of subjects.

17 Jun 2007

New era of treatment for rheumatoid arthritis

Three new drugs for rheumatoid arthritis (RA) have ushered in a new era of treatment for this difficult and debilitating condition.

16 Jun 2007

Swift system for heart attack care improves treatment

Heart attack patients received lifesaving care up to an hour sooner after an Indiana hospital implemented a novel protocol to rapidly activate the cardiac catheterization lab, researchers reported in Circulation: Journal of the American Heart Association.

16 Jun 2007

Sonographically-guided alcohol injections for Morton's neuroma highly successful

Sonographically-guided alcohol injections has a high success rate and is well tolerated by patients with Morton?s neuroma, a common cause of foot pain, according to a recent study conducted by researchers at the Royal National Orthopaedic Hospital and Kingston Hospital NHS Trust in Middlesex, United Kingdom.

16 Jun 2007

Anticonvulsant medication gabapentin effective for fibromyalgia pain

New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.

14 Jun 2007

Priority review granted for oral formulation of HYCAMTIN (topotecan)

GlaxoSmithKline (GSK) has announced that its new drug application (NDA) for ORAL HYCAMTIN (topotecan) capsules, a treatment for relapsed small cell lung cancer (SCLC), has been granted Priority Review by the United States Food and Drug Administration (FDA).

14 Jun 2007

Eurand files NDA for Zentase for the treatment of exocrine pancreatic insufficiency

Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.

14 Jun 2007

First comprehensive description of sleep and wake patterns of cancer patients using continuous polysomnography

Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.

14 Jun 2007

Will list of symptoms for ovarian cancer save lives?

The American Cancer Society along with CancerCare, Gilda's Club and several other medical groups have released a consensus statement listing the symptoms for ovarian cancer.

13 Jun 2007

NHS surplus reignites anger over staged pay award

UNISON has reiterated its demand for ministers to use the record NHS surplus to pay health workers their due - and avert the growing strike threat.

8 Jun 2007

Facts about heart disease for women

Many women don't worry about heart disease, or if they do, they are concerned it's something the men in their lives might develop.

8 Jun 2007

Examination of cancer-related fatigue

In a special publication sent to thousands of oncologists nationwide this month, University of Rochester Medical Center scientists offer an in-depth examination of cancer-related fatigue, with hope that a better understanding of the topic will prompt new research and treatment.

8 Jun 2007